Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Cloud Computing Market for Cell Biology, Genomics and Drug Development, 2025-2030 | AI-Enabled Platforms Drive 16.7% CAGR Toward $15.6 Billion

globenewswire.com
GOOGL Alphabet Inc. (Google) is mentioned as a leading participant in the global cloud computing market for cell biology, genomics, and drug development. The article highlights AI-enabled platforms as a key growth driver, a sector where Google is a major player. AMZN Amazon Web Services (AWS) Inc. is identified as a leading participant in the cloud computing market for life sciences. The growth of AI-enabled platforms and the increasing demand for scalable cloud infrastructure are positive indicators for AWS. IBM IBM Corp. is listed as a leading participant in the cloud computing market for cell biology, genomics, and drug development. The article's focus on AI-enabled platforms and the overall market growth suggests potential opportunities for IBM's cloud services. MSFT Microsoft is mentioned as a leading participant in the global cloud computing market for cell biology, genomics, and drug development. The article's emphasis on AI-driven platforms and the overall market expansion presents a positive outlook for Microsoft's cloud offerings. ORCL Oracle Corp. is identified as a leading participant in the cloud computing market for life sciences. The article's projection of significant market growth, driven by AI and data management needs, suggests a neutral to positive outlook for Oracle's cloud services.

Global Cloud Computing Market for Cell Biology, Genomics and Drug Development, 2025-2030 | AI-Enabled Platforms Drive 16.7% CAGR Toward $15.6 Billion Dublin, Oct. 23, 2026 (GLOBE NEWSWIRE) -- "Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets" has been added to ResearchAndMarkets.com's offering.

The global cloud computing market serving cell biology, genomics and drug development was valued at USD 7.2 Billion in 2025 and is projected to reach USD 15.6 Billion by 2030, rising at a CAGR of 16.7%. Market growth is being driven by increasing demand for scalable, secure and AI-enabled platforms capable of managing the substantial volumes of data generated across life sciences research and pharmaceutical development.

The adoption of precision medicine and multiomics research is accelerating demand for cloud-based infrastructure. Researchers, clinicians, pharmaceutical companies and biotechnology organizations increasingly use these platforms to analyze genomic, transcriptomic, proteomic and clinical datasets. Advances in high-performance computing (HPC), federated learning and AI-driven bioinformatics pipelines are improving discovery workflows, supporting more efficient clinical trial design and enabling real-time integration of real-world evidence (RWE).

The report presents global revenue data for 2024 and market estimates for the 2025 through 2030 forecast period. It evaluates the market by branch of biology, deployment type, application, end user and region, providing detailed insight into growth opportunities and competitive positioning.

By branch of biology, the analysis covers human biology, microbiology, animal biology and plant biology. Deployment categories include public cloud, private cloud and hybrid cloud. Application segments comprise discovery and preclinical research, clinical trials, pharma manufacturing, plant and microbial gene analysis, and commercialization.

End-user analysis includes pharmaceutical and biotechnology companies, clinical laboratories, contract research organizations (CROs), and other organizations operating in academia, government and agritech. The geographic assessment covers North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of major national markets within each region.

The report examines the technologies and commercial strategies shaping cloud computing adoption across life sciences. Key areas include venture capital (VC) and corporate investment, regulatory developments, enterprise strategies, precision medicine initiatives and population genomics programs. It also assesses macroeconomic conditions, tariff considerations, market barriers and emerging opportunities relevant to investors, policymakers, technology providers and life sciences organizations.

Competitive analysis provides company rankings, market share insights and profiles of leading participants. The report evaluates strategic initiatives, partnerships, M&A activity, venture funding and collaborations between cloud service providers and pharmaceutical or biotechnology companies. Featured companies include Alphabet Inc. (Google), Amazon Web Services (AWS) Inc., IBM Corp., Microsoft and Oracle Corp.

Key report coverage includes:

By combining market forecasts, technology analysis, regulatory insights and competitive intelligence, the report offers a comprehensive resource for organizations seeking to evaluate the expanding role of cloud computing in genomics, cell biology research, pharmaceutical R&D and drug development.

Key Attributes:

Key Topics Covered:

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Technologies and Developments

Chapter 6 Market Segmentation Analysis

Chapter 7 Patent Review/New Developments

Chapter 8 Competitive Landscape

Chapter 9 Appendix

List of Tables [103]

List of Figures [28]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/2qcsdo

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.